Pinan Liu M.D., Ph.D.
Professor, Department of Neurosurgery, Capital Medical University, Beijing, China
Deputy Director, Neurosurgical center, Beijing Tiantan Hospital, Beijing, China
Director, Department of Neurosurgery Ward 9, Beijing Tiantan Hospital, Beijing, China
Director, Department of Neural Reconstruction, Beijing Neurosurgical Institute, Capital Medical University, Beijing China
President, Beijing Children’s Tumor Foundation, Beijing, China
Dr. Pinan Liu, professor in neurosurgery, is a member of the Chinese Medical Doctor Association, Chinese Anti-Cancer Association, the academic head of the Beijing public health system, and the editor of Chinese Journal of Neurosurgery. He graduated from Capital Medical University in 1999. Demin Han and Zhongcheng Wang, two prominent academicians of China Engineering Academy, were his tutors when he was pursuing his master’s and doctoral degrees respectively.
His work is mainly focused on clinical and biological research in skull base lesions and his excellent professional skills have been deployed in the surgical treatment of intracranial and extracranial communicating tumors, skull base reconstruction, endoscopic endonasal surgery, repair of cerebrospinal fluid rhinorrhea, pituitary adenoma resection, acoustic neuroma resection, auditory reconstruction, and in the comprehensive treatment of neurofibromatosis type 2 (NF2), etc. After becoming a chief neurosurgeon of Beijing Tiantan Hospital in 2004, he and his team have performed skull base surgeries numbering more than several hundred each year. His outstanding outcomes have been published in several authoritative journals, such as Neurosurgery and Journal of Neurosurgery. His expertise lies in endoscopic surgeries and he has personally performed around 2,000 endoscopic surgeries for various skull base lesions.
Dr. Pinan Liu is also interested in the study of neurofibromatosis type 2 (NF2). He established the first research group of neurofibromatosis in China and worked in close collaboration with several famous institutions, such as the Massachusetts General Hospital and Johns Hopkins Hospital. The research done by his team has confirmed the main types of hereditary NF2 gene mutations in Chinese Han people and determined the mutational hotspots. The research group he established has also explored the link between NF2 gene mutation type and phenotype. Their study of auditory brainstem implant (ABI) in NF2 patients, the first of its kind in China, was funded by the Twelfth Five-Year National Science and Technology Support Program. The team developed the domestic multi-channel electronic auditory brainstem independently, which included speech coding strategy, implantable devices, and related productive technology. Dr. Liu’s interests also lie in understanding brain cognitive functions and the pathological mechanisms of brain tumors. The team’s outstanding research results have been published in PLOS One, Scientific Reports, Neuro-oncology, etc. His tremendous research achievements in the field of neurosurgery have been duly acknowledged and recognized by the Beijing Municipal Government, Chinese Ministry of Public Health, and the Chinese Ministry of Education on several occasions.